Prophylaxis for children with moderate hemophilia: Use of a guideline to increase early initiation

Abstract

Percent of hemophilia patients prescribed prophylaxis at an encounter in 2016 (before the clinical guideline) compared to 2018 (after the clinical guideline), shown for all patients and then shown by baseline factor level. The number of patient encounters reviewed (N) for each year and baseline factor level are displayed below the x-axis. B, Reasons given for prophylaxis in patients with a baseline factor level from 2 to 5% in 2016 compared to 2018. This includes 18 patients with encounters reviewed in both 2016 and 2018